CR20220208A - Sistemas y métodos de aislamiento de galio-68 - Google Patents

Sistemas y métodos de aislamiento de galio-68

Info

Publication number
CR20220208A
CR20220208A CR20220208A CR20220208A CR20220208A CR 20220208 A CR20220208 A CR 20220208A CR 20220208 A CR20220208 A CR 20220208A CR 20220208 A CR20220208 A CR 20220208A CR 20220208 A CR20220208 A CR 20220208A
Authority
CR
Costa Rica
Prior art keywords
systems
gallium
isolation
methods
processes
Prior art date
Application number
CR20220208A
Other languages
English (en)
Inventor
Joel Oscar Olsson Kumlin
Original Assignee
Artms Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Artms Products Inc filed Critical Artms Products Inc
Publication of CR20220208A publication Critical patent/CR20220208A/es

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/10Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/18Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
    • B01D15/1864Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns
    • B01D15/1871Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns placed in series
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0402Organic compounds carboxylic acid carriers, fatty acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0497Organic compounds conjugates with a carrier being an organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/083Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/265Adsorption chromatography
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/42Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/424Elution mode
    • B01D15/426Specific type of solvent
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J45/00Ion-exchange in which a complex or a chelate is formed; Use of material as complex or chelate forming ion-exchangers; Treatment of material for improving the complex or chelate forming ion-exchange properties
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J47/00Ion-exchange processes in general; Apparatus therefor
    • B01J47/02Column or bed processes
    • B01J47/026Column or bed processes using columns or beds of different ion exchange materials in series
    • GPHYSICS
    • G21NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21GCONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/04Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators
    • G21G1/10Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators by bombardment with electrically charged particles
    • GPHYSICS
    • G21NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21GCONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/001Recovery of specific isotopes from irradiated targets
    • G21G2001/0021Gallium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Manufacture And Refinement Of Metals (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Catalysts (AREA)
  • Recrystallisation Techniques (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

En un aspecto, la descripción se refiere a procesos para la preparación de una solución de Ga-68 sin portador a partir de un ensamble de objetivo sólido, sistemas que comprenden componentes que se usan en los procesos descritos y composiciones que comprenden Ga-68 preparadas mediante los procesos descritos. Se pretende que este resumen sea una herramienta de exploración para propósitos de búsqueda en la técnica particular y no pretende ser limitante de la presente descripción
CR20220208A 2019-10-12 2020-10-12 Sistemas y métodos de aislamiento de galio-68 CR20220208A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962914476P 2019-10-12 2019-10-12
PCT/IB2020/059581 WO2021070164A1 (en) 2019-10-12 2020-10-12 Systems and methods of isolation of gallium-68

Publications (1)

Publication Number Publication Date
CR20220208A true CR20220208A (es) 2022-09-14

Family

ID=75438061

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20220208A CR20220208A (es) 2019-10-12 2020-10-12 Sistemas y métodos de aislamiento de galio-68

Country Status (9)

Country Link
US (3) US12121828B2 (es)
EP (1) EP4041426A4 (es)
JP (1) JP2022551697A (es)
KR (1) KR20220093127A (es)
CN (1) CN114761100A (es)
AU (1) AU2020364423A1 (es)
BR (1) BR112022006863A8 (es)
CR (1) CR20220208A (es)
WO (1) WO2021070164A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024025023A (ja) * 2022-08-10 2024-02-26 住友重機械工業株式会社 放射性同位体精製装置、及び放射性同位体精製方法
CN116594053B (zh) * 2023-07-18 2024-01-19 清华大学 放射性溶液中超铀α核素、90Sr和137Cs的组分离系统及装置

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2461681A1 (fr) * 1979-07-20 1981-02-06 Rhone Poulenc Ind Perfectionnement au procede de recuperation de l'uranium d'un acide phosphorique impur
US5326441A (en) * 1990-01-19 1994-07-05 European Economic Community Process for separating and concentrating gallium from an aqueous solution containing gallium, together with aluminum, zinc and copper
GB0308407D0 (en) * 2003-04-11 2003-05-21 Amersham Plc Method of obtaining 68 GA
TW200740709A (en) * 2005-07-26 2007-11-01 Dro Biosystems S L Static support bed for purification, separation, detection, modification and/or immobilization of target entities and method using thereof
WO2010072342A2 (en) * 2008-12-22 2010-07-01 Bayer Schering Pharma Aktiengesellschaft A method for the synthesis of a radionuclide-labeled compound
FR3019547B1 (fr) * 2014-04-03 2017-12-22 Univ Paris Sud 11 Nouveaux complexes pour la separation de cations
EP4615169A3 (en) * 2014-05-15 2025-12-10 Mayo Foundation for Medical Education and Research Solution target for cyclotron production of radiometals
PT3101660T (pt) * 2015-06-05 2017-09-18 Ion Beam Appl Sa Processo de produção de gálio-68 através de irradiação de um alvo em solução
WO2017170934A1 (ja) * 2016-04-01 2017-10-05 国立大学法人 東京大学 新規化合物とその合成方法
US11446398B2 (en) * 2016-04-11 2022-09-20 Obsidian Therapeutics, Inc. Regulated biocircuit systems
EP3503929B1 (en) * 2016-08-26 2022-02-23 Mayo Foundation for Medical Education and Research Rapid isolation of cyclotron-produced gallium-68
KR20200044005A (ko) * 2017-07-31 2020-04-28 스테판 제이슬러 고체 타겟을 사용하여 입자 가속기 상에서 갈륨 방사성 동위 원소를 생산하기 위한 시스템, 장치 및 방법과, 이에 의해 생산된 ga-68 조성물
WO2020118426A1 (en) * 2018-12-11 2020-06-18 Societe de Commercialisation des Produits de la Recherche Appliquée Socpra Sciences et Génie S.E.C. Processes and systems for producing and/or purifying gallium-68

Also Published As

Publication number Publication date
WO2021070164A1 (en) 2021-04-15
EP4041426A4 (en) 2022-11-23
US20220351873A1 (en) 2022-11-03
CN114761100A (zh) 2022-07-15
KR20220093127A (ko) 2022-07-05
AU2020364423A1 (en) 2022-04-21
US20250249381A1 (en) 2025-08-07
BR112022006863A2 (pt) 2022-07-05
US20240390818A1 (en) 2024-11-28
JP2022551697A (ja) 2022-12-13
CA3156951A1 (en) 2021-04-15
EP4041426A1 (en) 2022-08-17
US12121828B2 (en) 2024-10-22
BR112022006863A8 (pt) 2022-08-02

Similar Documents

Publication Publication Date Title
BR112021023457A2 (pt) Composto, uso do composto, composição, e, métodos para preparar a composição e um composto
CL2020001048A1 (es) Anticuerpos monoclonales contra bcma. (divisional solicitud 201800281)
CL2018000182A1 (es) Compuesto que se dirige a il-23a y al factor de activación de linfocitos b (baff) y usos de estos
MX2020001598A (es) Inhibidores selectivos de proteína arginina metiltransferasa 5 (prmt5).
BR112016012883A2 (pt) Métodos e composições para aprimorar o rendimento de milho
ECSP19089214A (es) Inhibidores de quinasa y usos de los mismos
BR112015024308A2 (pt) microalgas do gênero euglena, método para produzir polissacarídeose, método para produzir um composto orgânico
CO2017002253A2 (es) Compuesto dirigido a il-23a y tnf-alfa
MX2021000151A (es) Metodo para obtener saponinas a partir de plantas.
MX2018003827A (es) Anticuerpos anti-cd19 humano con alta afinidad.
MX392571B (es) Procesos para producir productos de fermentación.
EA201691649A1 (ru) Способ получения противогрибковых соединений
UY37015A (es) Inhibidores de la tirosina quinasa de bruton y métodos de su uso
MX2018007084A (es) Inhibidores de la tirosina quinasa de bruton y metodos de su uso.
CR20220208A (es) Sistemas y métodos de aislamiento de galio-68
BR112019025028A2 (pt) Método para preparar um composto.
MX2022001694A (es) Metodos y composiciones para mejorar el rendimiento de soya.
MX2018015938A (es) Metodos para inhibir la conversion de colina en trimetilamina (tma).
WO2015175042A3 (en) Blade outer air seal fin cooling assembly and method
ECSP19081839A (es) Método para preparar intermedio de derivado de 4-metoxipirrol
BR112016012627A2 (pt) composições compreendendo um polipeptídeo de beta-glicosidase e métodos de uso
WO2018085833A3 (en) Selective inhibitors of protein arginine methyl transferase 5 (prmt5)
CL2018003654A1 (es) Preparación de derivados del factor xa.
MX373709B (es) Proceso para la purificacion de ga-68 a partir del eluato que se deriva de generadores de 68ge/ 68ga y columnas cromatograficas para usarse en dicho proceso.
MX2020003081A (es) Metodos para inhibir la conversion de colina en trimetilamina (tma).